Danish Pharmaceuticals & Biotech Most Popular Stocks

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Genmab

Market Cap: DKK 113.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

ALK-Abelló

Market Cap: DKK 52.2b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

H. Lundbeck

Market Cap: DKK 41.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Zealand Pharma

Market Cap: DKK 20.8b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Bavarian Nordic

Market Cap: DKK 13.8b

Develops, manufactures, and supplies life-saving vaccines.

ChemoMetec

Market Cap: DKK 7.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Gubra

Market Cap: DKK 5.8b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

BioPorto

Market Cap: DKK 574.3m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia.

Pharma Equity Group

Market Cap: DKK 108.0m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which the current therapy is lacking or in need of improvement.

Stenocare

Market Cap: DKK 44.1m

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.

Strategic Partners

Market Cap: DKK 29.0m

Does not have significant operations.